Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-14 Sale | 2026-03-25 4:30 pm | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 15,496 | $1.0272 | $15,917 | 81,309 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-24 Option Award | 2026-03-25 5:05 pm | N/A 2036-03-24 | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 45,867 | $0 | 45,867 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-02 09:03 am | N/A 2035-03-31 | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 36,979 | $0.98 | 36,979 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:32 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 38,741 | $0 | 96,805 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:43 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 58,064 | $0 | 58,064 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 5:44 pm | N/A 2032-08-11 | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 236,220 | $0 | 236,220 (Direct) | View |
Ownership | 2021-10-21 8:41 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | HUMPHREY RACHEL Director | 0 | $0 | 58,133 (Direct) | View |